Polynucleotide useful for modulating cancer cell proliferation

Details for Australian Patent Application No. 2002335492 (hide)

International Classifications

Event Publications

13 February 2003 Complete Application Filed

Priority application(s): 01/02801 01.03.01 FR

13 March 2003 Application Open to Public Inspection

Published as AU-B-2002335492

2 November 2006 Application Accepted

Published as AU-B-2002335492

1 March 2007 Standard Patent Sealed

12 March 2009 Alteration of Name

The name of the patentee has been altered to Centre National De La Recherche Scientifique (CNRS); IPSEN Pharma S.A.S

27 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.